rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2009-6-4
|
pubmed:databankReference |
|
pubmed:abstractText |
In several statin trials, vascular event rates for treatment groups begin to separate 1 year after commencement of treatment. For atherosclerosis progression, the temporal sequence of the effect has not been defined. We used data from the Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin (METEOR) trial to determine the earliest time point at which significant differences in atherosclerosis progression rates could be detected after initiation of statin therapy.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1365-2796
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
265
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
698-707
|
pubmed:dateRevised |
2009-11-30
|
pubmed:meshHeading |
pubmed-meshheading:19298496-Aged,
pubmed-meshheading:19298496-Anticholesteremic Agents,
pubmed-meshheading:19298496-Carotid Artery Diseases,
pubmed-meshheading:19298496-Cholesterol, LDL,
pubmed-meshheading:19298496-Disease Progression,
pubmed-meshheading:19298496-Double-Blind Method,
pubmed-meshheading:19298496-Female,
pubmed-meshheading:19298496-Fluorobenzenes,
pubmed-meshheading:19298496-Humans,
pubmed-meshheading:19298496-Hypercholesterolemia,
pubmed-meshheading:19298496-Male,
pubmed-meshheading:19298496-Middle Aged,
pubmed-meshheading:19298496-Pyrimidines,
pubmed-meshheading:19298496-Sulfonamides,
pubmed-meshheading:19298496-Time Factors,
pubmed-meshheading:19298496-Treatment Outcome,
pubmed-meshheading:19298496-Tunica Intima
|
pubmed:year |
2009
|
pubmed:articleTitle |
Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study.
|
pubmed:affiliation |
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands. m.l.bots@umcutrecht.nl
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|